Ct-DNA Testing Could Alter Treatment, Improve Outcomes In Certain Patients With Cancer Of Unknown Primary, Research Indicates.

Medscape (10/29, Davenport, Subscription Publication) reports that “more than two thirds of patients with cancer of unknown primary (CUP) have mutations detectable on circulating tumor DNA (ct-DNA) testing,” and “for these patients, ct-DNA testing could...